BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

BMEDvsRSPHETF Comparison

ETF 1

BMED

iShares Health Innovation Active ETF

This fund is part of

Healthcare Technology

-0.39%

Full BMED fund page

VS

ETF 2

RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of

US Health Care

-0.28%

Full RSPH fund page

iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. Invesco S&P 500® Equal Weight Health Care ETF (RSPH) is part of the US Health Care segment. BMED's top 2 sector exposures are Healthcare and Non-Corporate. In contrast, RSPH's top sector exposures are Healthcare and Consumer Non-Cyclicals. BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.4% for RSPH. BMED is up 11.92% year-to-date (YTD) with +$5M in YTD flows. RSPH performs better with 17.95% YTD performance, and -$30M in YTD flows. Run a side-by-side ETF comparison of BMED and RSPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

BMED vs RSPH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 08/31/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	BMED RSPH	+9.10%+7.55%	+19.32%+20.71%	+11.92%+17.95%	+28.87%+28.62%	+41.47%+31.69%	+11.08%+22.75%
Flows	BMED RSPH	+$1M+$13M	+$1M+$69M	+$5M-$30M	+$7M-$44M	+$7M-$345M	+$6M-$265M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	BMED RSPH	+22.14%+21.15%	+17.46%+16.74%	+16.64%+15.82%	+18.01%+16.76%
Max drawdown	BMED RSPH	-4.62%-3.58%	-14.71%-10.87%	-19.76%-16.96%	-33.96%-21.91%
Max drawdown duration	BMED RSPH	32d20d	196d116d	237d434d	1586d817d

Trading data

Create an account to view trading data

Join for free

	BMED	RSPH
Last sale 9/1/2026 at 1:30 PM	$33.80	$37.47
Previous close 08/31/2026	$33.81	$37.40
Consolidated volume 08/31/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of August 31, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

BMED

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	BMED	RSPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 9/1/2026 at 1:30 PM

Live

Closed

	BMED	RSPH
Last price	$33.80	$37.47
1D performance	-0.03%	+0.19%
AuM	$13.52 M	$837.12 M
E/R	0.77%	0.4%

Characteristics

	BMED	RSPH
Management strategy	Active	Passive
Provider	iShares	Invesco
Benchmark	-	S&P 500 Equal Weight Health Care Index
N° of holdings	53	59
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	September 29, 2020	November 1, 2006
ESG	No	No

More BMED data on Trackinsight

More RSPH data on Trackinsight

Exposure

Countries

BMED

USA

86.04%

Other

13.96%

RSPH

USA

96.6%

Other

3.4%

Sectors

BMED

Healthcare

95.69%

Other

4.31%

RSPH

Healthcare

98.34%

Other

1.66%

Diversification

BMED

Total weight of top 15 holdings out of 15

56.15%

RSPH

Total weight of top 15 holdings out of 15

28.14%

Top 15 holdings

Data as of July 31, 2026

BMED

Merck & Co., Inc.

5.85%

Gilead Sciences, Inc.

4.87%

Johnson & Johnson

4.45%

Edwards Lifesciences Corp.

4.43%

Thermo Fisher Scientific, Inc.

4.17%

Charles River Laboratories International, Inc.

3.72%

Danaher Corp.

3.63%

Biogen, Inc.

3.58%

Waters Corp.

3.50%

AbbVie, Inc.

3.50%

Mettler-Toledo International, Inc.

3.37%

Moderna, Inc.

3.07%

Vertex Pharmaceuticals, Inc.

2.96%

BlackRock Cash Funds - Treasury

2.58%

Amgen, Inc.

2.49%

RSPH

Bio-Techne Corp.

2.10%

IQVIA Holdings, Inc.

2.08%

Veeva Systems, Inc.

1.95%

Charles River Laboratories International, Inc.

1.93%

Mettler-Toledo International, Inc.

1.89%

Baxter International, Inc.

1.87%

DaVita, Inc.

1.86%

Abbott Laboratories

1.86%

Incyte Corp.

1.85%

Thermo Fisher Scientific, Inc.

1.83%

Moderna, Inc.

1.82%

AbbVie, Inc.

1.79%

Universal Health Services, Inc.

1.78%

Regeneron Pharmaceuticals, Inc.

1.77%

Quest Diagnostics, Inc.

1.77%

Frequently asked questions about BMED and RSPH

How have the BMED and RSPH ETFs performed in 2026?

As of August 31, 2026, BMED is up 11.92% year-to-date (YTD), while RSPH has returned 17.95%. That puts RSPH better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or RSPH?

Year-to-date, the BMED ETF saw +$5M in flows, compared to -$30M for RSPH.

Which ETF is more volatile: BMED or RSPH?

Over the past year, BMED had a volatility of 17.46%, while RSPH experienced 16.74%.

Which ETF is bigger: BMED or RSPH?

As of August 31, 2026, BMED holds $13.52 M in assets under management (AUM), while RSPH manages $837.12 M.

What sectors do the BMED and RSPH ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, RSPH focuses on Healthcare.

What are the top holdings of the BMED ETF and RSPH ETF?

BMED top holdings include Merck & Co., Inc., Gilead Sciences, Inc. and Johnson & Johnson. RSPH holds in its top three: Bio-Techne Corp., IQVIA Holdings, Inc. and Veeva Systems, Inc..

Which ETF is more diversified: BMED or RSPH?

BMED holds 56 securities with 56.15% of its assets in the top 15. RSPH has 59 securities and a top 15 weight of 28.14%.

Tony's ETF Buyers Guide: Equal-Weight ETFs

May 14, 2024

RSPH

BMEDvsRSPHETF Comparison

iShares Health Innovation Active ETF

Invesco S&P 500® Equal Weight Health Care ETF

BMED vs RSPH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the BMED and RSPH ETFs performed in 2026?

As of August 31, 2026, BMED is up 11.92% year-to-date (YTD), while RSPH has returned 17.95%. That puts RSPH better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or RSPH?

Year-to-date, the BMED ETF saw +$5M in flows, compared to -$30M for RSPH.

Which ETF is more volatile: BMED or RSPH?

Over the past year, BMED had a volatility of 17.46%, while RSPH experienced 16.74%.

Which ETF is bigger: BMED or RSPH?

As of August 31, 2026, BMED holds $13.52 M in assets under management (AUM), while RSPH manages $837.12 M.

What sectors do the BMED and RSPH ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, RSPH focuses on Healthcare.

What are the top holdings of the BMED ETF and RSPH ETF?

BMED top holdings include Merck & Co., Inc., Gilead Sciences, Inc. and Johnson & Johnson. RSPH holds in its top three: Bio-Techne Corp., IQVIA Holdings, Inc. and Veeva Systems, Inc..

Which ETF is more diversified: BMED or RSPH?

BMED holds 56 securities with 56.15% of its assets in the top 15. RSPH has 59 securities and a top 15 weight of 28.14%.

Tony's ETF Buyers Guide: Equal-Weight ETFs

Have you tried our ETF Compare tool?